Screener
Upstream Bio, Inc. UPB Investing Cash Flow
Investing Cash Flow at other companies
Other financials
Where this comes from
Reported directly by Upstream Bio, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NetCashProvidedByUsedInInvestingActivities.
The source filing: Upstream Bio, Inc.’s 10-Q, filed August 11, 2026.
- Filed
- Aug 11, 2026, 7:10 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-343417
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Purchases of short-term investments | (65,363) | (323,138) |
| Maturities of short-term investments | 123,524 | 122,577 |
| Purchases of equipment | — | (47) |
| Net cash provided by (used in) investing activities | 58,161 | (200,608) |
| Cash flows from financing activities: | ||
| Proceeds from issuance of common stock in connection with at-the-market offering, net of commissions | 2,083 | — |
| Proceeds from issuance of common stock under stock plans | 1,048 | 612 |
| Payments of initial public offering costs | — | (34) |
Item 1. Financial Statements.
FAQ
- What is Upstream Bio, Inc.'s investing cash flow?
- Upstream Bio, Inc. (UPB) reported investing cash flow of $15.76M in Q2 2026.
- What does investing cash flow mean?
- Total net cash provided by or used in investing activities — capex, acquisitions, investment purchases/sales, and other investing items.
Ask your AI about Upstream Bio, Inc.'s investing cash flow.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude